Sherwin-Williams (NYSE:SHW - Get Free Report) had its price target decreased by stock analysts at UBS Group from $420.00 to $380.00 in a report released on Thursday,Benzinga reports. The firm presently has a "buy" rating on the specialty chemicals company's stock. UBS Group's target price indicates a potential upside of 19.44% from the company's current price.
Other equities research analysts have also recently issued research reports about the company. Weiss Ratings reiterated a "hold (c+)" rating on shares of Sherwin-Williams in a research note on Friday, March 27th. Royal Bank Of Canada lowered their target price on shares of Sherwin-Williams from $390.00 to $376.00 and set an "outperform" rating on the stock in a report on Thursday, March 19th. Vertical Research upgraded shares of Sherwin-Williams from a "hold" rating to a "buy" rating and set a $371.00 price target for the company in a research note on Wednesday, January 7th. Citigroup lowered their price objective on shares of Sherwin-Williams from $410.00 to $385.00 and set a "buy" rating on the stock in a research note on Wednesday. Finally, Mizuho cut their target price on shares of Sherwin-Williams from $410.00 to $371.00 and set an "outperform" rating for the company in a research note on Monday, March 23rd. Eleven investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, Sherwin-Williams presently has a consensus rating of "Moderate Buy" and an average price target of $383.23.
View Our Latest Stock Analysis on Sherwin-Williams
Sherwin-Williams Stock Down 2.3%
SHW stock traded down $7.56 during mid-day trading on Thursday, hitting $318.14. 953,957 shares of the company were exchanged, compared to its average volume of 1,812,815. The company has a debt-to-equity ratio of 2.03, a quick ratio of 0.53 and a current ratio of 0.87. Sherwin-Williams has a 1-year low of $301.58 and a 1-year high of $379.65. The firm's 50 day simple moving average is $343.60 and its 200 day simple moving average is $339.94. The firm has a market cap of $78.70 billion, a P/E ratio of 30.99, a P/E/G ratio of 2.78 and a beta of 1.27.
Sherwin-Williams (NYSE:SHW - Get Free Report) last issued its quarterly earnings data on Thursday, January 29th. The specialty chemicals company reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.16 by $0.07. The company had revenue of $5.60 billion during the quarter, compared to the consensus estimate of $5.57 billion. Sherwin-Williams had a net margin of 10.90% and a return on equity of 65.26%. The firm's revenue was up 5.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.09 earnings per share. On average, sell-side analysts predict that Sherwin-Williams will post 12 EPS for the current fiscal year.
Insider Activity
In related news, SVP Bryan J. Young sold 2,513 shares of the company's stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $364.47, for a total value of $915,913.11. Following the transaction, the senior vice president owned 10,045 shares in the company, valued at approximately $3,661,101.15. This represents a 20.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Colin M. Davie sold 2,976 shares of the stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $359.50, for a total transaction of $1,069,872.00. Following the completion of the transaction, the insider directly owned 5,365 shares in the company, valued at approximately $1,928,717.50. This represents a 35.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.23% of the stock is owned by corporate insiders.
Institutional Trading of Sherwin-Williams
Hedge funds have recently added to or reduced their stakes in the company. Cornerstone Planning LLC acquired a new position in Sherwin-Williams in the 4th quarter valued at $2,435,000. Rockefeller Capital Management L.P. increased its position in shares of Sherwin-Williams by 7.2% in the fourth quarter. Rockefeller Capital Management L.P. now owns 106,890 shares of the specialty chemicals company's stock worth $34,636,000 after purchasing an additional 7,149 shares during the period. World Investment Advisors raised its stake in Sherwin-Williams by 127.4% in the fourth quarter. World Investment Advisors now owns 5,545 shares of the specialty chemicals company's stock valued at $1,797,000 after purchasing an additional 3,107 shares in the last quarter. Demming Financial Services Corp ADV bought a new stake in Sherwin-Williams during the fourth quarter worth about $1,063,000. Finally, Larry Mathis Financial Planning LLC bought a new stake in Sherwin-Williams during the fourth quarter worth about $221,000. 77.67% of the stock is owned by institutional investors and hedge funds.
Sherwin-Williams Company Profile
(
Get Free Report)
Sherwin-Williams NYSE: SHW is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.
The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.